rs121918392
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PP2PP5BS1_Supporting
The NM_000041.4(APOE):c.61G>A(p.Glu21Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000633 in 1,612,122 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Consequence
NM_000041.4 missense
Scores
Clinical Significance
Conservation
Publications
- Alzheimer disease 2Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hyperlipoproteinemia type 3Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- lipoprotein glomerulopathyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp
- sea-blue histiocyte syndromeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000041.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APOE | NM_000041.4 | MANE Select | c.61G>A | p.Glu21Lys | missense | Exon 3 of 4 | NP_000032.1 | ||
| APOE | NM_001302688.2 | c.139G>A | p.Glu47Lys | missense | Exon 3 of 4 | NP_001289617.1 | |||
| APOE | NM_001302689.2 | c.61G>A | p.Glu21Lys | missense | Exon 3 of 4 | NP_001289618.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APOE | ENST00000252486.9 | TSL:1 MANE Select | c.61G>A | p.Glu21Lys | missense | Exon 3 of 4 | ENSP00000252486.3 | ||
| APOE | ENST00000425718.1 | TSL:1 | c.61G>A | p.Glu21Lys | missense | Exon 2 of 3 | ENSP00000410423.1 | ||
| APOE | ENST00000434152.5 | TSL:2 | c.139G>A | p.Glu47Lys | missense | Exon 3 of 4 | ENSP00000413653.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000365 AC: 9AN: 246676 AF XY: 0.0000224 show subpopulations
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1459790Hom.: 0 Cov.: 32 AF XY: 0.0000565 AC XY: 41AN XY: 726212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE5 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at